Pharmena S.A.(PL:PHR)
zł 2.85+-0.01 (+1.79%)
PL:PHR
Pharmena S.A. financials statements
zł 2.85
At close:+-0.01 (+1.79%)
Pharmena S.A. (PHR) Ratios
0 Followers
Pharmena S.A. Ratios
PL:PHR's free cash flow for Q2 2026 was zł-882.00K. For the 2026 fiscal year, PL:PHR's free cash flow was decreased by zł-173.00K and operating cash flow was zł-709.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 9.20 | 12.98 | 13.17 | 0.59 | 0.71 |
| Quick Ratio | 8.47 | 12.23 | 12.92 | 0.32 | 0.41 |
| Cash Ratio | 0.36 | 1.91 | 12.56 | 0.09 | 0.13 |
| Solvency Ratio | -2.08 | -1.12 | 15.35 | -0.05 | -0.24 |
| Operating Cash Flow Ratio | -2.78 | -2.77 | 18.65 | 0.11 | -0.28 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 16516.00 | 0.24 | -0.68 |
| Net Current Asset Value | zł 7.75M | zł 10.77M | zł 21.42M | zł -9.40M | zł -8.07M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.02 | 0.01 | 0.81 | 0.87 |
| Debt-to-Equity Ratio | 0.04 | 0.02 | 0.01 | -1.56 | -2.00 |
| Debt-to-Capital Ratio | 0.04 | 0.02 | 0.01 | 2.78 | 2.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | -0.49 | -6.10 |
| Financial Leverage Ratio | 1.13 | 1.09 | 1.07 | -1.94 | -2.29 |
| Debt Service Coverage Ratio | -159.10 | -54.92 | 55.72 | -0.04 | -0.74 |
| Interest Coverage Ratio | -164.05 | -89.39 | 65.79 | -0.70 | -15.03 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.15 | 0.10 |
| Interest Debt Per Share | 0.03 | 0.03 | 0.06 | 0.98 | 0.90 |
| Net Debt to EBITDA | -0.00 | 0.44 | -0.62 | -66.29 | -2.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 75.40% | 73.88% | 59.40% | 3456.52% | 51.48% |
| EBIT Margin | -208.05% | -1269.78% | 358.11% | -1358.19% | -27.22% |
| EBITDA Margin | -200.19% | -1261.94% | 361.41% | -43.14% | -23.11% |
| Operating Profit Margin | -208.05% | -1267.54% | 354.49% | -169.90% | -26.18% |
| Pretax Profit Margin | -174.00% | -954.10% | 354.34% | -1656.86% | -29.30% |
| Net Profit Margin | -175.59% | -470.90% | 294.21% | -525.08% | -30.18% |
| Continuous Operations Profit Margin | -175.59% | -470.90% | 274.65% | -1725.08% | -30.49% |
| Net Income Per EBT | 100.91% | 49.35% | 83.03% | 31.69% | 103.03% |
| EBT Per EBIT | 83.63% | 75.27% | 99.96% | 975.20% | 111.90% |
| Return on Assets (ROA) | -25.35% | -9.33% | 119.93% | -12.48% | -41.18% |
| Return on Equity (ROE) | -28.70% | -10.16% | 128.51% | 24.19% | 94.39% |
| Return on Capital Employed (ROCE) | -33.01% | -26.94% | 155.95% | 11.57% | 932.79% |
| Return on Invested Capital (ROIC) | -32.65% | -13.21% | 129.11% | -14.89% | -86.36% |
| Return on Tangible Assets | -29.06% | -10.18% | 120.50% | -13.56% | -45.09% |
| Earnings Yield | -9.56% | -2.96% | 36.60% | -2.52% | -5.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.44 | 3.53 | 32.25 | 0.08 | 4.76 |
| Payables Turnover | 0.87 | 0.16 | 5.26 | 1.19 | 1.50 |
| Inventory Turnover | 0.54 | 0.10 | 8.98 | 1.90 | 2.13 |
| Fixed Asset Turnover | 3.73 | 0.88 | 38.28 | 0.60 | 18.83 |
| Asset Turnover | 0.14 | 0.02 | 0.41 | 0.02 | 1.36 |
| Working Capital Turnover Ratio | 0.17 | 0.02 | 1.35 | -0.06 | -4.87 |
| Cash Conversion Cycle | 360.94 | 1412.29 | -17.38 | 4541.31 | 4.73 |
| Days of Sales Outstanding | 106.01 | 103.51 | 11.32 | 4657.11 | 76.73 |
| Days of Inventory Outstanding | 673.56 | 3592.64 | 40.67 | 191.72 | 171.20 |
| Days of Payables Outstanding | 418.62 | 2283.86 | 69.36 | 307.52 | 243.20 |
| Operating Cycle | 779.56 | 3696.15 | 51.98 | 4848.83 | 247.93 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.24 | -0.23 | 2.97 | 0.16 | -0.29 |
| Free Cash Flow Per Share | -0.27 | -0.24 | 2.94 | 0.14 | -0.32 |
| Dividend Paid and CapEx Coverage Ratio | -11.50 | -0.26 | 105.20 | 8.05 | -10.11 |
| Capital Expenditure Coverage Ratio | -11.50 | -14.06 | 105.20 | 8.05 | -10.11 |
| Operating Cash Flow Coverage Ratio | -7.45 | -10.37 | 180.50 | 0.18 | -0.33 |
| Operating Cash Flow to Sales Ratio | -1.73 | -9.44 | 3.36 | 6.08 | -0.21 |
| Free Cash Flow Yield | -10.23% | -6.36% | 41.37% | 2.55% | -4.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.40 | -34.82 | 2.73 | -39.73 | -19.14 |
| Price-to-Sales (P/S) Ratio | 18.36 | 159.17 | 8.04 | 208.60 | 5.78 |
| Price-to-Book (P/B) Ratio | 3.00 | 3.43 | 3.51 | -9.61 | -18.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.78 | -15.74 | 2.42 | 39.15 | -24.80 |
| Price-to-Operating Cash Flow Ratio | -10.63 | -16.85 | 2.39 | 34.29 | -27.25 |
| Price-to-Earnings Growth (PEG) Ratio | -0.08 | 0.33 | -0.00 | 0.60 | 0.55 |
| Enterprise Value Multiple | -9.18 | -12.17 | 1.60 | -549.79 | -27.35 |
| Enterprise Value | 28.97M | 41.16M | 57.02M | 70.92M | 96.13M |
| EV to EBITDA | -9.18 | -12.17 | 1.60 | -549.79 | -27.35 |
| EV to Sales | 18.37 | 153.57 | 5.80 | 237.20 | 6.32 |
| EV to Free Cash Flow | -9.78 | -15.18 | 1.74 | 44.52 | -27.12 |
| EV to Operating Cash Flow | -10.63 | -16.26 | 1.73 | 38.99 | -29.81 |
| Tangible Book Value Per Share | 0.74 | 1.01 | 1.99 | -0.70 | -0.55 |
| Shareholders’ Equity Per Share | 0.87 | 1.12 | 2.02 | -0.58 | -0.44 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.51 | 0.17 | -0.04 | -0.04 |
| Revenue Per Share | 0.14 | 0.02 | 0.88 | 0.03 | 1.37 |
| Net Income Per Share | -0.25 | -0.11 | 2.60 | -0.14 | -0.41 |
| Tax Burden | 1.01 | 0.49 | 0.83 | 0.32 | 1.03 |
| Interest Burden | 0.84 | 0.75 | 0.99 | 1.22 | 1.08 |
| Research & Development to Revenue | 0.00 | 0.04 | 0.00 | 0.51 | 0.01 |
| SG&A to Revenue | 2.91 | 13.34 | 0.36 | 10.79 | 0.31 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.98 | 2.01 | 1.14 | -1.29 | 0.72 |
Currency in PLN
